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Summary A 14-year-old boy was referred to our hospital because of treatment of germ cell
tumor in the anterior mediastinum. Computerized tomographic (CT) scan of the chest and
abdomen revealed a large tumor in the anterior mediastinum and multiple metastatic tumors
in the lung, liver, kidney, pancreas, and heart. There was a mass in the interventricular septum.
A 24-h Holter monitor showed sinus rhythm with 358 premature ventricular complexes (VPC)
and 30 ventricular runs including 9 non-sustained ventricular tachycardias per day. The patient
was treated with 4 cycles of chemotherapy with good response. Approximately 12 weeks after
the start of the chemotherapy, serial CT scan showed regression of the tumors in the anterior
mediastinum, lung, and kidney, and disappearance of the tumors in the liver, pancreas, and
heart. Repeat Holter monitor showed that VPC and ventricular runs disappeared completely.
The chemotherapy for the germ cell tumor was very useful for ventricular arrhythmias secondary
to cardiac metastasis of the tumor.
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etastatic tumors of the ventricle rarely cause ventricu-
ar tachycardia (VT) [1—3]. Such patients usually have very
oor prognosis. We report a case of advanced mediastinal
erm cell tumor with non-sustained VT secondary to car-
iac metastasis which disappeared after chemotherapy to
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he tumor. This is an extremely uncommon report that the
hemotherapy for the tumor was effective in the control of
entricular arrhythmias secondary to cardiac metastasis.
ase report
n June 2009, a 14-year-old boy was referred to our hospi-
al because of treatment of germ cell tumor in the anterior
ediastinum. Computerized tomographic (CT) scan of the
hest and abdomen in the previous hospital revealed a large
umor in the anterior mediastinum and multiple metastatic
umors in the lung, liver, kidney, pancreas, and heart. There
Published by Elsevier Ireland Ltd. All rights reserved.
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tFigure 1 Computerized tomographic scan of the chest. (A)
ventricular septum (arrow). (B) After the chemotherapy for
disappeared.
was a mass in the interventricular septum (Fig. 1). The
patient was diagnosed with germ cell tumor by needle biopsy
of the mediastinal tumor in the hospital. He had no previ-
ous history of cardiovascular diseases. One month earlier,
he complained of pain in the right shoulder. However, he did
not complain of any cardiac symptoms.
On physical examination the patient had a temperature
of 36.5 ◦C with a respiratory rate of 22 breaths/min, blood
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Figure 2 A 24-h Holter monitor. (A) On admission, there were 358 p
runs. (B) After the chemotherapy for germ cell tumor in the anterior mdmission, there was a cardiac metastatic tumor in the inter-
cell tumor in the anterior mediastinum, the cardiac tumor
ressure of 95/72mmHg, and a pulse rate of 76 bpm with
rrhythmia. He had bilateral gynecomastia and moist rale in
he bilateral lungs. The patient had a lactate dehydrogenase
LDH) level of 2180 IU/L, an alkaline phosphatase (ALP) level
f 498 IU/L, and a -human chorionic gonadotropin (HCG)
evel of 2900 ng/ml. The chest radiograph showed a large
umor in the mediastinum and multiple pulmonary tumors.
is electrocardiograms had been within normal limits except
remature ventricular complexes (VPC) including 30 ventricular
ediastinum, VPC and ventricular runs disappeared completely.
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tricular diastolic collapse. J Cardiol 2009;53:447—52.igure 3 Transthoracic echocardiography. (A) On admission
ovement of interventricular septum were recognized (arrow
ediastinum, all abnormalities of interventricular septum disap
or non-speciﬁc T wave change. A 24-h Holter monitor
howed sinus rhythm with some premature ventricular com-
lexes (VPC). The computer counted 358VPC. There were
0 ventricular runs including 9 non-sustained VT (Fig. 2).
he VPC and runs were usually monophasic. Transthoracic
chocardiography (TTE) demonstrated thickness, granular
parkling appearance, and slightly reduced movement of
nterventricular septum (Fig. 3), global left ventricular sys-
olic function was normal (ejection fraction, 70%). There
as no involvement of any other cardiac structure.
The patient was treated with 4 cycles of chemother-
py with cisplatin, etoposide, and bleomycin, and no
ntiarrhythmic agents. He had a good response to the
hemotherapy. Approximately 12 weeks after the start of
he 4 cycles of chemotherapy, the patient had an LDH level
f 193 IU/L, a ALP level of 371 IU/L, and a -HCG level of
.8 ng/ml. Serial CT scan showed regression of the tumors
n the anterior mediastinum, lung, and kidney, and disap-
earance of the tumors in the liver, pancreas, and heart.
erial TEE showed disappearance of thickness, granular
parkling appearance, and reduced movement of interven-
ricular septum, and within normal limits. Repeat Holter
onitor showed that VPC and ventricular runs disappeared
ompletely. The computer counted 0 VPC (Fig. 2). He was in
ood condition and received further chemotherapy.
iscussion
n contrast to primary cardiac tumor, metastatic involve-
ent of the heart is relatively common. As an example,
n one of the largest autopsy series of over 7200 patients
ying of malignancies, cardiac metastasis was found in 9%
4]. About two thirds of all cardiac metastases involved the
ericardium, one third the epicardium or the myocardium,
nd only 5% the endocardium. The most common clinical
anifestation of cardiac metastasis is symptoms due to
ardiac tamponade [4—7]. Tumors spreading extensively to
he pericardium result in pericardial effusion. However, a
ocal lesion secondary to the myocardium may usually result
n no symptoms [4]. Rare cases involving the myocardium
resented arrhythmias, such as atrial ﬁbrillation or ﬂut-
er, ventricular arrhythmias, and conduction disturbances
1,2,3,8].
[ckness, granular sparkling appearance, and slightly reduced
) After the chemotherapy for germ cell tumor in the anterior
red.
Several possible mechanisms of ventricular arrhythmias
ssociated with the myocardium may be considered. First,
he site of insertion of the tumor may be the focus of
acro-entry. Second, the insertion of the tumor into nor-
al myocardium may alter normal tissue architecture to
ause localized dispersion of repolarization, anisotropic con-
uction, and microre-entry. Third, local compression of
yocardial ﬁbers or release of humoral elements may cause
n automatic VT [1].
After complete remission of the cardiac metastasis with
hemotherapy in our case, VPC and ventricular runs dis-
ppeared completely. The chemotherapy for the germ cell
umor was very useful to control ventricular arrhythmias
econdary to cardiac metastasis of the tumor.
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